Prevalence of fecal carriage of vancomycin resistant Enterococci in a tertiary care centre in South India

Vinitha Murugesan; Dhanalakshmi Gounassegarane; Gnanaprakash Karanam; Jayalakshmi Jayarajan

doi:10.18203/2320-6012.ijrms20250689

Authors

Vinitha Murugesan Department of Microbiology, KMCH Institute of Health Sciences and Research, Coimbatore, Tamil Nadu, India
Dhanalakshmi Gounassegarane Department of Microbiology, KMCH Institute of Health Sciences and Research, Coimbatore, Tamil Nadu, India
Gnanaprakash Karanam Department of Microbiology, KMCH Institute of Health Sciences and Research, Coimbatore, Tamil Nadu, India
Jayalakshmi Jayarajan Department of Microbiology, KMCH Institute of Health Sciences and Research, Coimbatore, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20250689

Keywords:

Faecal carriers, Health care workers, Vancomycin resistant Enterococci

Abstract

Background: The number of VRE infections gradually increases worldwide and ICUs in hospitals which remains to be the major reservoir of antibiotic-resistant organisms. The current study was carried out to determine prevalence of fecal carriers of vancomycin resistant Enterococci in a tertiary care hospital, thereby preventing the spread of vancomycin resistant Enterococci to patients under high risk.

Methods: A total of 219 stool samples and rectal swabs were collected from health care workers and ICU patients and processed in vancomycin resistant Enterococci agar and subjected to certain phenotypic tests for its species identification. Antimicrobial susceptibility testing was done for all the vancomycin resistant enterococcal isolates.

Results: A total of 73 VRE were isolated of which 64 (36%) were from HCW and 9 (22%) were from ICU patients. The prevalence of VRE was 33% and the most common VRE isolated was Enterococcus faecium. All the 73 VRE isolates were susceptible to linezolid and 52% were susceptible to quinpristine/dalfopristine.

Conclusions: Screening of stool samples aids in the prevention of spread of multi-drug resistant VRE isolate from HCW to high risk patients. It’s imperative to step up infection control strategies so as to curtail its spread.

Metrics

Metrics Loading ...

References

Amberpet R, Sistla S, Parija SC, Thabah MM. Screening for intestinal colonization with vancomycin resistant Enterococci and associated risk factors among patients admitted to an adult intensive care unit of a large teaching hospital. J Clin Diagn Res. 2016;10: DC06-9. DOI: https://doi.org/10.7860/JCDR/2016/20562.8418

Huskins CW, Huckabee CM, O’Grady NP, Murry P. Intervention to reduce transmission of resistnt bacteria in intensive care. N Engl J Med. 2011;364:1407-18. DOI: https://doi.org/10.1056/NEJMoa1000373

Zirakzadeh A, Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proceed. 2006;81(4):529-36. DOI: https://doi.org/10.4065/81.4.529

Tripathi A, Shukla SK, Singh A, Prasad KN. Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a tertiary care hospital in northern India. Indian J Med Microbiol. 2016;34(1):38-45. DOI: https://doi.org/10.4103/0255-0857.174099

Ziakas PD, Thapa R, Rice LB, Mylonakis E. Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS One. 2013;8(9).e75658 DOI: https://doi.org/10.1371/journal.pone.0075658

Baran J, Ramanathan J, Riederer KM, Khatib R. Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households. Infect Control Hosp Epidemiol. 2002;23(1):23-6. DOI: https://doi.org/10.1086/501963

Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis. 1996;23(4):767-72. DOI: https://doi.org/10.1093/clinids/23.4.767

Praharaj I, Sujatha S, Parija SC. Phenotypic and genotypic characterization of vancomycin resistant Enterococcus isolates from clinical specimens. Indian J Med Res. 2013;138(4):549.

Taneja N, Rani P, Emmanuel R, Sharma M. Significance of vancomycin resistant enterococci from urinary specimens at a tertiary care centre in northern India. Indian J Med Res. 2004;119(2):72.

Papadimitriou-Olivgeris M, Drougka E, Fligou F, Kolonitsiou F, Liakopoulos A, Dodou V, et al. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients. Infection. 2014;42(6):1013-22. DOI: https://doi.org/10.1007/s15010-014-0678-1

Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century- a clinical super-challenge. N Engl J Med. 2009;360(5):439-43. DOI: https://doi.org/10.1056/NEJMp0804651

Baldir G, Engin DO, Kucukercan M, Asuman IN, Akçay S, Ozyurek S, et al. High-level resistance to aminoglycoside, vancomycin, and linezolid in enterococci strains. J Microbiol Infect Dis. 2013;3(03):100-3. DOI: https://doi.org/10.5799/ahinjs.02.2013.03.0090